About UsUnderstanding AMLInterviewsGlobal NetworkGet InvolvedStoriesResources

Does race affect treatment outcome in AML?

Ann-Kathrin Eisfeld

January 6, 2021

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, Know AML spoke to Ann-Kathrin Eisfeld, OSUCCC – The James, Columbus, US, about the impact of race on treatment outcome in AML. Results from a recent study on patients treated over three decades in the US indicate that African-American patients do poorly compared with white patients diagnosed with leukemia. Eisfeld explains the possible reasons for the different outcomes.